Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Public ClinicalTrials.gov record NCT01431339. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Dalbavancin to a Comparator Regimen (Vancomycin and Linezolid) for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary object is to compare the early clinical efficacy (after 48-72 hours of therapy) of dalbavancin to the comparator regimen (vancomycin with the option to switch to oral linezolid) for the treatment of patients with a suspected or proved gram-positive bacterial skin or skin structure infections.
Study identification
- NCT ID
- NCT01431339
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 739 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2011 (Type not available)
- Primary completion
- Nov 2012 (Actual)
- Completion
- Dec 2012 (Actual)
- Last update posted
- Feb 12, 2014
2011 – 2012
United States locations
- U.S. sites
- 30
- U.S. states
- 11
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Durata Clinical Site | Montgomery | Alabama | 36106 | — |
| Durata Clinical Site | Anaheim | California | 92804 | — |
| Durata Clinical Site | Buena Park | California | 90620 | — |
| Durata Study Site | Chula Vista | California | 91911 | — |
| Durata Clinical Site | Long Beach | California | 90813 | — |
| Durata Study Site | Los Angeles | California | 90015 | — |
| Durata Study Site | Norwalk | California | 90650 | — |
| Durata Study Site | Oxnard | California | 93030 | — |
| Durata Study SIte | San Diego | California | 92120 | — |
| Durata Study Site | Stockton | California | 95204 | — |
| Durata Clinical Site | Boyton Beach | Florida | 33435 | — |
| Durata Clinical Site | Fort Meyers | Florida | 33966 | — |
| Durata Clinical Site | Miami | Florida | 33015 | — |
| Durata Study Site | Orlando | Florida | 32837 | — |
| Durata Clinical Site | Saint Cloud | Florida | 34769 | — |
| Durata Clinical Site | Augusta | Georgia | 30901 | — |
| Durata Study Site | Columbus | Georgia | 31904 | — |
| Durata Clinical Site | Chicago | Illinois | 60637 | — |
| Durata Study Site | Baton Rouge | Louisiana | 70809 | — |
| Durata Study Site | New Orleans | Louisiana | 70112 | — |
| Durata Study Site | Shreveport | Louisiana | 71101 | — |
| Durata Study Site | Zachary | Louisiana | 70791 | — |
| Durata Study Site | Las Vegas | Nevada | 89109 | — |
| Durata Study Site | Springfield | Ohio | 45502 | — |
| Durata Study Site | Philadelphia | Pennsylvania | 19103 | — |
| Durata Study Site | Austin | Texas | 78701 | — |
| Durata Clinical Site | Austin | Texas | 78752 | — |
| Durata Clinical Site | Houston | Texas | 77055 | — |
| Durata Study Site | Richmond | Texas | 77469 | — |
| Durata Study Site | Middleton | Wisconsin | 53562 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 107 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01431339, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 12, 2014 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01431339 live on ClinicalTrials.gov.